Az onkokardiológiai ellátás új irányelvei

András Nagy(University of Szeged), Judit Kocsis(Bács-Kiskun Megyei Kórház), Ingrid Balogh, Dániel Czuriga(University of Debrecen), Mária Lódi(University of Debrecen)

University of Debrecen Electronic Archive (University of Debrecen)

January 1, 2017

Cited by 0

Related Papers

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

|The Lancet|2023|319

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

|The Lancet Oncology|2019|282

A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms

|Cardiovascular Drugs and Therapy|2024|38

Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference

|Journal of Clinical Immunology|2021|28

Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy

|Journal of Translational Medicine|2020|14